![Artwork](/static/images/128pixel.png)
Go offline with the Player FM app!
Wintrust Business Minute: UIC scientists developing new bacterial resistant antibiotic
Manage episode 430663181 series 3035618
Steve Grzanich has the business news of the day with the Wintrust Business Minute.
Scientists at the University of Illinois-Chicago are working on a new antibiotic that’ll make bacterial resistance nearly impossible. The new antibiotic attacks bacteria is two ways, which makes it 100 million times more difficult for bacteria to develop resistance. That resistance can make it difficult and sometimes impossible to treat infections. Bacterial resistance can sometimes be fatal and it’s considered to be a global health threat. The UIC scientists have been studying a class of synthetic antibiotics called macrolones that interfere with protein production within cells of bacteria and corrupt the structure of its DNA. Because bacteria would have to to fight off both attacks simultaneously, drug resistance would be nearly impossible. UIC researchers worked with Chinese scientists on the antibiotic but more study is needed before it becomes available for human treatment.
Also, Northfield-based Medline Industries may be moving toward an initial public offering. Listen for more below:
Recent Posts
Wintrust Business Lunch
102 episodes
Manage episode 430663181 series 3035618
Steve Grzanich has the business news of the day with the Wintrust Business Minute.
Scientists at the University of Illinois-Chicago are working on a new antibiotic that’ll make bacterial resistance nearly impossible. The new antibiotic attacks bacteria is two ways, which makes it 100 million times more difficult for bacteria to develop resistance. That resistance can make it difficult and sometimes impossible to treat infections. Bacterial resistance can sometimes be fatal and it’s considered to be a global health threat. The UIC scientists have been studying a class of synthetic antibiotics called macrolones that interfere with protein production within cells of bacteria and corrupt the structure of its DNA. Because bacteria would have to to fight off both attacks simultaneously, drug resistance would be nearly impossible. UIC researchers worked with Chinese scientists on the antibiotic but more study is needed before it becomes available for human treatment.
Also, Northfield-based Medline Industries may be moving toward an initial public offering. Listen for more below:
Recent Posts
Wintrust Business Lunch
102 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.